MR Imaging in Multiple Sclerosis: Review and Recommendations for Current Practice

被引：70

作者：

Loevblad, K.-O. ^{[1
]}

Anzalone, N. ^{[2
]}

Doerfler, A. ^{[4
]}

Essig, M. ^{[5
]}

Hurwitz, B. ^{[6
]}

Kappos, L. ^{[7
]}

Lee, S. -K. ^{[8
]}

Filippi, M. ^{[3
]}

机构：

[1] Univ Hosp Geneva, Diagnost Neuroradiol Unit, Dept Radiol, CH-1211 Geneva 14, Switzerland

[2] Ist Sci San Raffaele, Dept Neuroradiol, I-20132 Milan, Italy

[3] Ist Sci San Raffaele, Neuroimaging Res Unit, Dept Neurol, I-20132 Milan, Italy

[4] Univ Erlangen Nurnberg, Dept Neuroradiol, Erlangen, Germany

[5] German Canc Res Ctr, Dept Radiol, D-6900 Heidelberg, Germany

[6] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA

[7] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland

[8] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea

来源：

AMERICAN JOURNAL OF NEURORADIOLOGY | 2010年 / 31卷 / 06期

关键词：

NEPHROGENIC SYSTEMIC FIBROSIS; CLINICALLY ISOLATED SYNDROMES; 1ST DEMYELINATING EVENT; CONTRAST AGENTS; GADOBENATE-DIMEGLUMINE; DIAGNOSTIC-CRITERIA; GLATIRAMER ACETATE; ENHANCING LESIONS; DOSE GADOTERIDOL; NATURAL-HISTORY;

D O I：

10.3174/ajnr.A1906

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

MR imaging is widely used for the diagnosis and monitoring of patients with MS. Applications and protocols for MR imaging continue to evolve, prompting a need for continual reassessments of the optimal use of this technique in clinical practice. This article provides updated recommendations on the use of MR imaging in MS, based on a review of the trial evidence and personal experiences shared at a recent expert meeting of radiologists and neurologists.

引用

页码：983 / 989

页数：7

共 58 条

[1] MRI in multiple sclerosis: current status and future prospects
Bakshi, Rohit
Thompson, Alan J.
Rocca, Maria A.
Pelletier, Daniel
Dousset, Vincent
Barkhof, Frederik
Inglese, Matilde
Guttmann, Charles R. G.
Horsfield, Mark A.
Filippi, Massimo
[J]. LANCET NEUROLOGY, 2008, 7 (07) : 615 - 625
[2] Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis
Barkhof, F
Filippi, M
Miller, DH
Scheltens, P
Campi, A
Polman, CH
Comi, G
Ader, HJ
Losseff, N
Valk, J
[J]. BRAIN, 1997, 120 : 2059 - 2069
[3] Benner T, 2000, J MAGN RESON IMAGING, V12, P371, DOI 10.1002/1522-2586(200009)12:3<371::AID-JMRI1>3.0.CO
[4] 2-3
[5] Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: Valus of spinal MR imaging
Bot, JCJ
Barkhof, F
Nijeholt, GLA
van Schaardenburg, D
Voskuyl, AE
Ader, HJ
Pijnenburg, JAL
Polman, CH
Uitdehaag, BMJ
Vermeulen, EGJ
Castelijns, JA
[J]. RADIOLOGY, 2002, 223 (01) : 46 - 56
[6] A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
Brex, PA
Ciccarelli, O
O'Riordan, JI
Sailer, M
Thompson, AJ
Miller, DH
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (03) : 158 - 164
[7] CLINICAL NMR IMAGING OF THE BRAIN - 140 CASES
BYDDER, GM
STEINER, RE
YOUNG, IR
HALL, AS
THOMAS, DJ
MARSHALL, J
PALLIS, CA
LEGG, NJ
[J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1982, 139 (02) : 215 - 236
[8] Chan LL, 2007, ANN ACAD MED SINGAP, V36, P647
[9] MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation"
Charil, Arnaud
Yousry, Tarek A.
Rovaris, Marco
Barkhof, Frederik
De Stefano, Nicola
Fazekas, Franz
Miller, David H.
Montalban, Xavier
Simon, Jack H.
Polman, Chris
Filippi, Massimo
[J]. LANCET NEUROLOGY, 2006, 5 (10) : 841 - 852
[10] Effect of early interferon treatment on conversion to definite multiple sclerosis:: a randomised study
Comi, G
Filippi, M
Barkhof, F
Durelli, L
Edan, G
Fernández, O
Hartung, HP
Seeldrayers, P
Sorensen, PS
Rovaris, M
Martinelli, V
Hommes, OR
[J]. LANCET, 2001, 357 (9268) : 1576 - 1582

← 1 2 3 4 5 6 →